Bolt Biotherapeutics, Inc.
BOLT
$5.79
$0.132.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -57.48% | -53.69% | -55.06% | -41.45% | -27.72% |
| Total Receivables | -21.11% | 34.58% | -84.82% | -50.00% | 80.00% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -22.39% | -32.71% | -27.53% | -37.89% | -40.70% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 371.35% | -- | -- | -- |
| Total Current Assets | -55.28% | -51.93% | -54.45% | -41.35% | -27.77% |
|
|
|||||
| Total Current Assets | -55.28% | -51.93% | -54.45% | -41.35% | -27.77% |
| Net Property, Plant & Equipment | 1.58% | 3.40% | -19.18% | -17.51% | -16.58% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -70.76% | -70.91% | -59.19% | -19.56% | 35.87% |
| Total Assets | -39.91% | -37.65% | -37.65% | -34.88% | -30.70% |
|
|
|||||
| Total Accounts Payable | -30.87% | -49.55% | -59.75% | -23.54% | 20.93% |
| Total Accrued Expenses | -35.64% | -33.17% | -0.21% | -25.84% | -6.04% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -16.87% | -19.09% | 5.37% | 16.04% | 16.22% |
| Total Finance Division Other Current Liabilities | 77.19% | 70.56% | 72.76% | 192.23% | 19.19% |
| Total Other Current Liabilities | 77.19% | 70.56% | 72.76% | 192.23% | 19.19% |
| Total Current Liabilities | -18.90% | -22.49% | -3.56% | 1.60% | 2.89% |
|
|
|||||
| Total Current Liabilities | -18.90% | -22.49% | -3.56% | 1.60% | 2.89% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 33.75% | 31.66% | -15.54% | -15.85% | -14.76% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -40.32% | -60.44% | -61.97% | -62.51% | -57.95% |
| Total Liabilities | 0.82% | -9.80% | -20.79% | -21.10% | -20.13% |
|
|
|||||
| Common Stock & APIC | 1.24% | 1.58% | 1.79% | 2.05% | 1.98% |
| Retained Earnings | -16.89% | -17.33% | -18.79% | -20.04% | -20.20% |
| Treasury Stock & Other | 211.11% | 162.16% | 217.82% | 80.79% | 84.68% |
| Total Common Equity | -55.06% | -49.27% | -43.84% | -39.59% | -33.95% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -55.06% | -49.27% | -43.84% | -39.59% | -33.95% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -55.06% | -49.27% | -43.84% | -39.59% | -33.95% |
|
|
|||||